Fig. 4From: EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinomaSurvival analyses and genetic variations of EFNA3 in LUAD. A–C Prognostic significance of EFNA3 expression in differential stage LUAD patients. D Genetic variations in the EFNA3 gene reported in different studies; E OncoPrint overview of the genetic variations in the EFNA3 geneBack to article page